Back to results
US 11,111,217 B2Granted
2-arylbenzimidazoles as Ppargc1a activators for treating neurodegenerative diseases
AssigneeThe Board of Trustees of the Leland Stanford Junior University
InventorsSamuel D. Banister, Edgar Engleman, Khoa D. Nguyen, Mark Smith
Life of this patent
Estimating the term…
Abstract
The compound 2-(4-tert-Butylphenyl)-1H-benzo[d]imidazol-5-ol: and its use are disclosed. The compound activates Ppargc1a and, as a consequence, is useful for treating neuroinflammation and for treating a variety of neurodegenerative diseases.
Claims3
A pharmaceutical composition comprising a compound of formula:
- or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier wherein the pharmaceutical composition is suitable for oral or parenteral administration.
Dependencies are inferred from the claim text.